Duloxetine Capsule, Delayed Release
Product Images NDC 71205-005

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71205-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure01 (Duloxetine Fig01)

The text describes a graph or chart showing the proportion of patients experiencing a relapse over time while undergoing placebo or Duloxetine treatment. The graph shows days from randomization on the x-axis and the proportion of patients with relapse on the y-axis.*

FDA Label Image

Figure2 (Duloxetine Fig02)

The text describes a graph showing the proportion of patients who experienced relapse over a certain period of time. The graph compares two treatments, a placebo and a medication called duloxetine. The x-axis shows the time from randomization to relapse in days, while the y-axis shows the percentage of patients who relapsed. The data displayed on the graph ranges from 0 to 300 days and shows that the proportion of patients who relapsed was lower in the duloxetine group than in the placebo group, with a significant difference after about 50 days.*

FDA Label Image

Figure04 (Duloxetine Fig04)

FDA Label Image

Figure07 (Duloxetine Fig07)

This is a clinical trial report indicating the effectiveness of Duloxetine 60/120 mg as a once-daily medication in reducing pain. The report shows graphs of the percentage of improvement in pain from baseline using a placebo.*

FDA Label Image

Figure08 (Duloxetine Fig08)

FDA Label Image

Figure09 (Duloxetine Fig09)

This is a description of a medication called Placebo with Duloxetine 60/120 mg that is taken once daily. The remaining text appears to be a chart or graph showing the percent improvement in pain from the baseline with different values on the x and y axes.*

FDA Label Image

Duloxetine-structure (Duloxetine Structure)

FDA Label Image

71205-005-60 (Duloxetine Delayed Release Capsules 20mg 60s)

This is a prescription drug labeled as Duloxetine 20mg capsules. It is dispensed with a medication guide and each capsule contains enteric-coated pellets of 22.4mg Duloxetine Hydrochloride USP. The capsules have a white body color with a blue color cap, and is imprinted with "DLX20" and “ap” on cap. It is manufactured by Ajanta Pharma USA Inc. and is made in India. The drug should be kept in a storage temperature of 25°C (77°F) and away from the reach of children. The lot number is 00000.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.